Literature DB >> 2858542

Identification of adrenoceptors and dopamine receptors mediating vascular responses in the superior mesenteric arterial bed of the rat.

A J Nichols, C R Hiley.   

Abstract

The nature of the adrenoceptors and dopamine receptors mediating vascular responses in the in-situ blood perfused superior mesenteric arterial bed of the rat have been studied. alpha 1-Adrenoceptor agonists produced vasoconstriction but alpha 2-agonists had no significant effect on vascular resistance. The vasoconstrictor effects of noradrenaline were antagonized by low doses of prazosin (26 nmol kg-1 i.v.). Isoprenaline and salbutamol produced vasodilation when the vasculature was preconstricted with arginine vasopressin. The responses to isoprenaline were potently antagonized by propranolol (1.69 mumol kg-1 i.v.) and weakly but significantly reduced by practolol (3.75 mumol kg-1 i.v.) whereas the responses to salbutamol were unaffected by the same dose of practolol. After preconstriction of the vasculature and alpha-adrenoceptor blockade, dopamine and apomorphine produced dilator responses with both compounds producing the same maximal response and apomorphine being 1.8 times more potent than dopamine. The dopamine responses were present after the animals had been pithed and were resistant to spiperone (506 nmol kg-1 i.v.) but were antagonized by cis-alpha-flupenthixol (460 nmol kg-1 i.v.). These results suggest that this vascular bed possesses vasoconstrictor alpha 1- but not alpha 2-adrenoceptors, vasodilator beta 1- and beta 2-adrenoceptors and vasodilator dopamine receptors which appear similar to the D1-type found centrally.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858542     DOI: 10.1111/j.2042-7158.1985.tb05017.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.

Authors:  W Nörenberg; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

2.  Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.

Authors:  A G Dupont; R A Lefebvre; P Vanderniepen
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

3.  [Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].

Authors:  A P Zou; N Parekh; M Steinhausen
Journal:  J Tongji Med Univ       Date:  1991

4.  Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries.

Authors:  P H Van der Graaf; P R Saxena; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

5.  Vasodilator responses to dopamine in rat perfused mesentery are age-dependent.

Authors:  J C Wanstall; S R O'Donnell
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

6.  Interactions between noradrenaline and alpha 2-adrenoceptor agonists in the superior mesenteric arterial bed of the rat.

Authors:  C R Hiley; A J Nichols; G R Thomas
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

7.  Effects of alpha-adrenoceptor agonists on cardiac output and its regional distribution in the pithed rat.

Authors:  C R Hiley; G R Thomas
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

8.  Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha 1- and alpha 2-adrenoceptor agonists in pithed normotensive rats.

Authors:  M R MacLean; C R Hiley
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

9.  Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture.

Authors:  A S Hall; S E Bryson; P F Vaughan; S G Ball; A J Balmforth
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.